Adverse consequences of high sympathetic nervous activity in the failing human heart
David M. Kaye(The Alfred Hospital), Murray Esler(Baker Heart and Diabetes Institute), Jeffrey Lefkovits(The Alfred Hospital), Garry Jennings, Archer Broughton(The Alfred Hospital), Peter Bergin(The Alfred Hospital)
Cited by 665
Related Papers
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial
|The Lancet|2010|2.2k
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study
|The Lancet|2009|2.1k
Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity.
|Circulation|1986|1k
Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions
|Physiological Reviews|1990|792
Renal Sympathetic-Nerve Ablation for Uncontrolled Hypertension
|New England Journal of Medicine|2009|774